The BioLecter system is most valuable for process development that involves screening numerous parameter combinations like media, pH, and induction profiles. It is particularly suited for organizations like CDMOs that require flexibility to work with different microorganisms and applications.
The misconception that automation equals simplicity causes teams to underestimate the need for experts in assay development, biology, and data analysis. This leads to poorly designed experiments and unreliable data when teams believe complex systems require just 'pushing a button.'
While tools like AI and robotics are transformative, a deep understanding of core principles like microbial physiology, mass transfer, and reaction kinetics remains essential. Technology augments, but does not replace, the critical thinking required to design robust experiments and interpret data.
The future of bioprocess development involves using AI on high-throughput data for predictive modeling. This, combined with in silico simulations (digital twins), will allow scientists to understand underlying biological mechanisms, not just identify optimal conditions, dramatically accelerating optimization.